![]() Conventional Treatment for Fibrocystic Breasts Additional investigation may include a mammogram, ultrasound, or biopsy if the abnormal findings are indicated on imaging. The most common assessment is through a clinical breast exam. Additional Lab Testsĭepending on your presentation, your primary care provider may want you to have multiple tests done. It also tests for beta-glucuronidase-producing bacteria and beta-galactosidase-producing bacteria, which are both involved in estrogen metabolism. Gut Zoomer 3.0 Complete by Vibrant Wellness is a comprehensive stool analysis that will analyze over 300 microorganisms, determining your status of beneficial versus pathogenic bacteria. While gut health has not been directly linked to fibrocystic breast disease, it is worthwhile to investigate gut microbiome health as it’s essential in hormone health. Having a healthy balance of bacteria in the gut can promote estrogen balance. Microbiome health is essential to the metabolism and use of circulating estrogen. This is ideal for women who are experiencing potential hormone imbalances or for monitoring hormone levels while taking HRT. The urine collection is a multi-day which provides insight into hormone fluctuation. Comprehensive Hormone PanelĭUTCH Complete is a dried urine test that looks at hormone metabolites. Evaluating sex hormones through hormone testing, while also assessing gut health, can provide insight into the root cause of this condition. Hormone imbalances are the primary driver of fibrocystic breast disease. Functional Medicine Labs to Test For The Root Cause Of Fibrocystic Breasts This constitutes a small percentage of the population and should be assessed based on an individual's current or past lifestyle history. One study found that 15 grams, around three alcoholic beverages, or more per day from ages 18-22, showed an increased association with benign breast diseases like fibrocystic breasts. One other area to consider is young adulthood alcohol consumption. The imbalance of estradiol to progesterone ratio, explicitly having a low E2/P, is correlated to an increased probability of developing fibrocystic breasts.Īdditionally, women who are on hormone replacement therapy ( HRT) of estrogen have a two-fold risk of experiencing breast tissue changes than those who do not take exogenous estrogen during menopause. The study found that those with fibrocystic breast disease had a significant drop in progesterone on day 24 and an increase in estrogen. One study evaluated this by measuring estradiol (E2) and progesterone (P), along with symptoms rating during days 21 and 24 of the luteal phase of the menstrual cycle. Elevated estrogen, with lower levels of progesterone, seems to play a key role in developing fibrocystic breasts in reproductive years. Universally, this condition is poorly understood but has primarily been linked to hormonal fluctuations. ![]() Fluctuation in the size of the lumps during menses.Discomfort in the upper outer part of the breast.Worsening pain from ovulation to menses.Here are examples of how breast tissue changes could feel: If you are experiencing any of these symptoms, they could be a sign of changes to your breast tissue. You may notice changes in your breast tissue as you age. ![]() After menopause, these breast changes can also occur with the use of hormone replacement therapy. ![]() The most common age range to see these changes is between 30 and 50 years old due to hormonal fluctuations. While this is a non-cancerous condition, it can be painful, especially during menstrual cycles. Fibro meaning fibrous thick tissue, and cystic, meaning fluid-filled sacs, will result in a ropey, lumpy, or knotty feeling along the breast tissues. Understanding the characteristics of these breast tissue changes, the common cause, and what steps you can take to mitigate or reduce the occurrence are all beneficial to supporting your health.īenign texture changes to the breast tissue can result in a condition known as fibrocystic breast. While that may be an initial fear, medical experts have concluded that fibrocystic breasts do not increase your risk for breast cancer. Women typically notice these changes on self-examination, which may alarm them with thoughts of breast cancer. This condition is a common presentation in premenopausal women due to the fluctuations that occur during the menstrual cycles. About 50% of women of reproductive age will experience breast tissue changes in the form of fibrocystic breasts.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |